@article{49983506be764c72a558ef8402f59945,
title = "Setting an agenda for comparative effectiveness systematic reviews in CKD care",
abstract = "Systematic reviews comparing the effectiveness of strategies to prevent, detect, and treat chronic kidney disease are needed to inform patient care. We engaged stakeholders in the chronic kidney disease community to prioritize topics for future comparative effectiveness research systematic reviews. We developed a preliminary list of suggested topics and stakeholders refined and ranked topics based on their importance. Among 46 topics identified, stakeholders nominated 18 as high priority. Most pertained to strategies to slow disease progression, including: (a) treat proteinuria, (b) improve access to care, (c) treat hypertension, (d) use health information technology, and (e) implement dietary strategies. Most (15 of 18) topics had been previously studied with two or more randomized controlled trials, indicating feasibility of rigorous systematic reviews. Chronic kidney disease topics rated by stakeholders as high priority are varied in scope and may lead to quality systematic reviews impacting practice and policy.",
keywords = "Chronic kidney disease, Evidence-based practice, Health services research",
author = "Crews, {Deidra C.} and Greer, {Raquel C.} and Fadrowski, {Jeffrey J.} and Choi, {Michael J.} and David Doggett and Segal, {Jodi B.} and Fawole, {Kemi A.} and Crawford, {Pammie R.} and Boulware, {L. Ebony}",
note = "Funding Information: We wish to thank the following individuals for participation among our CKD Community Stakeholders: Chester H. Fox, MD, Susan L. Furth, MD, PhD, Marva Moxey-Mims, MD, Andrew Narva, MD, Neil R. Powe, MD, Jennifer St. Clair Russell, MSEd, Nikolay Tchopev, MD, Paul M. Palevsky, MD, and Joseph A. Vassalotti, MD. Two of our stakeholders declined acknowledgement, however, we are grateful for their contributions to the project. This manuscript and the work it is derived from was commissioned by the Agency of Healthcare Research and Quality (AHRQ), through a contract to the Johns Hopkins University Evidence-based Practice Center (contract no. HHSA 290-2007-100061). Dr. Crews was supported by the Amos Medical Faculty Development Program of the Robert Wood Johnson Foundation, Princeton NJ. Dr. Fadrowski was supported by K23ES016541 from the National Institute of Environmental Health Science, Bethesda MD. Dr. Greer was supported by 5KL2RR025006 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.",
year = "2012",
doi = "10.1186/1471-2369-13-74",
language = "English (US)",
volume = "13",
journal = "BMC nephrology",
issn = "1471-2369",
publisher = "BioMed Central",
number = "1",
}